Freedman Edward D. 4
4 · Pandion Therapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Freedman Edward D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-08+36,895→ 36,895 totalExercise: $17.75Exp: 2031-02-07→ Common Stock (36,895 underlying)
Footnotes (1)
- [F1]This option award was granted on February 8, 2021. 1/4 of the shares underlying the award shall vest on February 8, 2022, with the remainder of the shares vesting in equal monthly installments following February 8, 2022 through February 8, 2025, subject to the reporting person's continued service on each applicable vesting date.